{
    "title": "Huntington's treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12365527/Huntingtons-drug-sales-help-Teva-Pharma-beat-profit-estimates.html",
    "date": "2023-08-02",
    "keywords": [
        "year",
        "drug",
        "share",
        "revenue",
        "francis",
        "uzedy",
        "teva",
        "scheer",
        "product",
        "ajovy",
        "debt",
        "pipeline",
        "market",
        "jerusalem",
        "wednesday",
        "secondquarter",
        "profit",
        "gain",
        "austedo",
        "treatment",
        "executive",
        "richard",
        "start",
        "trio",
        "bounce",
        "journey",
        "focus",
        "interview",
        "europe",
        "drugmaker",
        "loss",
        "exclusivity",
        "blockbuster",
        "sclerosis",
        "copaxone",
        "spate",
        "dyskenisa",
        "condition",
        "growth",
        "strategy",
        "latestage",
        "delivery",
        "earlystage",
        "development",
        "statement",
        "company",
        "ceo",
        "idea",
        "end",
        "biosimilar",
        "humira",
        "marketplace",
        "quarter",
        "america",
        "forecast",
        "versus",
        "reporting",
        "editing",
        "mark",
        "potter",
        "sitholematarise",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}